Wedbush Reiterates Outperform on Nuvalent, Maintains $99 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst David Nierengarten has reiterated an Outperform rating on Nuvalent (NASDAQ:NUVL) and maintained a price target of $99.
May 17, 2024 | 1:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst David Nierengarten has reiterated an Outperform rating on Nuvalent (NASDAQ:NUVL) and maintained a price target of $99.
The reiteration of an Outperform rating and a maintained price target of $99 by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100